BioSpace News Archive

The COVID-19 pandemic is having a devastating effect on global business and biopharma companies are not excluded.

Jeff Galvin, CEO of American Gene Technologies (AGT), had 30 years of business and entrepreneurial experience in Silicon Valley during the formative years of the personal computing and internet era.

ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications has selected LifeSphere® Signal and Risk Management as its next-generation signal detection tool.

A new breast cancer drug shown to significantly reduce the risk of cancer recurrence is now commercially available to Singapore patients.

MedinCell - Videoconference today in English at 3:00 pm CEST: https://invest.medincell.com/fr/conference/

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its audited financial results for the three months ended March 31, 2020 on Thursday, April 30, 2020 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m.

CMIC HOLDINGS Co., Ltd. announced that CMIC is providing monitoring services as a CRO for “Avigan® Tablet”, a product that FUJIFILM Toyama Chemical Co., Ltd. gained approval in Japan for manufacture and sale as an influenza antiviral drug, phase III clinical trial in Japan and will support for manufacturing the product as a CDMO..

The focusing of our operations protects the company’s liquidity, but is also part of our long-term strategy with a emphasis on clinical projects and innovation

Cytovance® Biologics announced that it has entered into a collaboration agreement with Akshaya Bio, Inc., a Canadian development stage biotechnology company to provide rapid access to clinical materials using Akshaya’s proprietary Chimigen® Platform Technology for vaccine development for COVID-19 and HBV..

Encision Inc. (PK: ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it entered into an unsecured promissory note under the Paycheck Protection Program (the “PPP”) for a principal amount